09.02.2013 Views

European Patent Bulletin 2012/36 - European Patent Office

European Patent Bulletin 2012/36 - European Patent Office

European Patent Bulletin 2012/36 - European Patent Office

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

(C07D) II.1(1)<br />

POLYMERISABLE COMPOUNDS FOR<br />

MAKING OPTO-ELECTRONIC DEVICES<br />

COMPOSÉS POLYMÉRISABLES POUR<br />

FABRIQUER DES DISPOSITIFS OPTOÉ-<br />

LECTRONIQUES<br />

(73) IMEC, Kapeldreef 75, 3001 Leuven, BE<br />

Universiteit Hasselt, Campus Diepenbeek<br />

Agoralaan - Gebouw D, 3590 Diepenbeek, BE<br />

(72) LUTSEN, Laurence, F-59210 Coudekerque-<br />

Branche, FR<br />

VANDERZANDE, Dirk, B-3500 Hasselt, BE<br />

CAMPO, Bert, B-2288 Bouwel, BE<br />

(74) Bird, William Edward, et al, Bird Goen & Co<br />

Klein Dalenstraat 42A, B-3020 Winksele, BE<br />

C07D 333/34 → (51) C07C 311/18<br />

C07D 333/68 → (51) C07D 471/04<br />

(51) C07D 401/04 (11) 2 358 698 B1<br />

A61K 31/501 C07D 401/14<br />

C07D 417/14<br />

(25) En (26) En<br />

(21) 09752059.7 (22) 05.11.2009<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(43) 24.08.2011<br />

(86) US 2009/063370 05.11.2009<br />

(87) WO 2010/056588 2010/20 20.05.2010<br />

(30) 17.11.2008 US 115332 P<br />

(54) TETRASUBSTITUIERTE PYRIDAZINE ALS<br />

ANTAGONISTEN DES HEDGEHOG-PFA-<br />

DES<br />

TETRASUBSTITUTED PYRIDAZINE AS<br />

HEDGEHOG PATHWAY ANTAGONISTS<br />

PYRIDAZINE TÉTRASUBSTITUÉE EN<br />

TANT QU' ANTAGONISTE DE LA VOIE DE<br />

SIGNALISATION HEDGEHOG<br />

(73) Eli Lilly and Company, Lilly Corporate<br />

Center, Indianapolis, IN 46285, US<br />

(72) BASTIAN, Jolie, Anne, Indianapolis, Indiana<br />

46285, US<br />

CLAY, Julia, Marie, Indianapolis, Indiana<br />

46285, US<br />

COHEN, Jeffrey, Daniel, Indianapolis, Indiana<br />

46285, US<br />

HIPSKIND, Philip, Arthur, Indianapolis,<br />

Indiana 46285, US<br />

LOBB, Karen, Lynn, Indianapolis, Indiana<br />

46285, US<br />

SALL, Daniel, Jon, Indianapolis, Indiana<br />

46285, US<br />

WILSON (NEE TAKAKUWA), Takako, Indianapolis,<br />

Indiana 46285, US<br />

THOMPSON, Michelle, Lee, Indianapolis,<br />

Indiana 46285, US<br />

(74) Bassinder, Emma Marie, Eli Lilly and<br />

Company Limited <strong>European</strong> <strong>Patent</strong><br />

Operations Lilly Research Centre, Erl Wood<br />

Manor Sunninghill Road, Windlesham,<br />

Surrey GU20 6PH, GB<br />

C07D 401/04 → (51) C07D 213/40<br />

C07D 401/04 → (51) C07D 213/56<br />

(51) C07D 401/06 (11) 2 234 997 B1<br />

C07D 471/04 C07D 207/26<br />

(25) En (26) En<br />

(21) 08863591.7 (22) 09.12.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

(43) 06.10.2010<br />

(86) EP 2008/0671<strong>36</strong> 09.12.2008<br />

(87) WO 2009/080500 2009/27 02.07.2009<br />

(30) 19.12.2007 EP 07150174<br />

(54) VERFAHREN ZUR HERSTELLUNG VON<br />

PYRIDO[2,1-A]ISOCHINOLINDERIVATEN<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

PROCESS FOR THE PREPARATION OF<br />

PYRIDO[2,1-A]ISOQUINOLINE DERI-<br />

VATIVES<br />

PROCÉDÉ DE PRÉPARATION DE DÉRIVÉS<br />

DE PYRIDO[2,1-A]ISOQUINOLÉINE<br />

(73) F. Hoffmann-La Roche AG, Grenzacherstrasse<br />

124, 4070 Basel, CH<br />

(72) ABRECHT, Stefan, CH-4202 Duggingen, CH<br />

ADAM, Jean-Michel, F-68128 Rosenau, FR<br />

FETTES, Alec, CH-8001 Zuerich, CH<br />

(74) Waschbüsch, Klaus, F. Hoffmann-La Roche<br />

AG Corporate Law <strong>Patent</strong>s Building 675 / 3rd<br />

Floor, 4070 Basel, CH<br />

C07D 401/06 → (51) C07D 213/40<br />

(51) C07D 401/12 (11) 2 346 850 B1<br />

(25) En (26) En<br />

(21) 09752269.2 (22) 26.10.2009<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(43) 27.07.2011<br />

(86) CZ 2009/000127 26.10.2009<br />

(87) WO 2010/045900 2010/17 29.04.2010<br />

(30) 24.10.2008 CZ 20080669<br />

(54) VERFAHREN ZUR HERSTELLUNG VON<br />

DABIGATRAN UND DESSEN ZWISCHEN-<br />

PRODUKTEN<br />

METHOD FOR THE PREPARATION OF<br />

DABIGATRAN AND ITS INTERMEDIATES<br />

PROCÉDÉ POUR PRÉPARER LE DABIGA-<br />

TRAN ET SES INTERMÉDIAIRES<br />

(73) Zentiva, K.S., U Kabelovny 130, 102 37<br />

Praha 10, CZ<br />

(72) LUSTIG, Petr, 530 03 Pardubice, CZ<br />

JIRMAN, Josef, 100 00 Praha 10, CZ<br />

(74) Jirotkova, Ivana, et al, Rott, Ruzicka &<br />

Guttmann <strong>Patent</strong>, Trademark and Law<br />

<strong>Office</strong>s Vinohradskà 37, 120 00 Praha 2, CZ<br />

C07D 401/12 → (51) C07D 213/40<br />

(51) C07D 401/14 (11) 2 271 640 B1<br />

C07D 471/04 A61K 31/435<br />

A61P 25/06 A61P 11/00<br />

(25) En (26) En<br />

(21) 09730504.9 (22) 03.04.2009<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK TR<br />

(43) 12.01.2011<br />

(86) US 2009/039444 03.04.2009<br />

(87) WO 2009/126530 2009/42 15.10.2009<br />

(30) 11.04.2008 US 44198 P<br />

(54) Piperidinderivate als CGRP-Rezeptorantagonisten<br />

Piperidine derivatives as CGRP receptor<br />

antagonists<br />

Antagonistes du récepteur CGRP<br />

(73) Bristol-Myers Squibb Company, Route 206<br />

and Province Line Road P.O. Box 4000,<br />

Princeton, NJ 08543-4000, US<br />

(72) LUO, Guanglin, Wallingford, CT 06492, US<br />

(74) Reitstötter - Kinzebach, <strong>Patent</strong>anwälte Sternwartstrasse<br />

4, 81679 München, DE<br />

C07D 401/14 → (51) C07D 401/04<br />

C07D 403/12 → (51) C07D 213/56<br />

C07D 403/12 → (51) C07D 241/28<br />

C07D 405/06 → (51) C07D 213/40<br />

(51) C07D 405/12 (11) 1 910 322 B1<br />

C07D 317/64 A61K 31/4525<br />

(25) En (26) En<br />

(21) 06813250.5 (22) 28.07.2006<br />

633<br />

<strong>Patent</strong>e<br />

<strong>Patent</strong>s<br />

Brevets (<strong>36</strong>/<strong>2012</strong>) 05.09.<strong>2012</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(43) 16.04.2008<br />

(86) US 2006/029599 28.07.2006<br />

(87) WO 2007/016431 2007/06 08.02.2007<br />

(30) 29.07.2005 US 704073 P<br />

(54) NEUE DEUTERIERTE BENZO [D][1,3]-DI-<br />

OXOL-DERIVATE ALS SEROTONINWIE-<br />

DERAUFNAHMEHEMMER<br />

NOVEL DEUTERATED BENZO [D][1,3]-<br />

DIOXOL DERIVATIVES AS SEROTONIN<br />

REUPTAKE INHIBITORS<br />

NOUVEAUX DERIVES DEUTERES DE<br />

BENZO [D][1,3]-DIOXOL EN TANT QU'<br />

INHIBITEURS DE LA RÉABSORPTION DE<br />

LA SÉROTONINE<br />

(73) Concert Pharmaceuticals Inc., 99 Hayden<br />

Avenue, Suite 100, Lexington, MA 02421,<br />

US<br />

(72) TUNG, Roger, Lexington, MA 02421, US<br />

(74) Reitstötter - Kinzebach, <strong>Patent</strong>anwälte Sternwartstrasse<br />

4, 81679 München, DE<br />

C07D 405/12 → (51) C07C 237/<strong>36</strong><br />

C07D 405/12 → (51) C07D 213/40<br />

C07D 405/12 → (51) C07D 215/14<br />

C07D 409/04 → (51) C07D 213/56<br />

C07D 409/12 → (51) C07C 237/<strong>36</strong><br />

C07D 409/12 → (51) C07C 311/18<br />

C07D 409/12 → (51) C07D 215/14<br />

C07D 409/14 → (51) C07C 237/<strong>36</strong><br />

(51) C07D 413/04 (11) 1 967 519 B1<br />

A61K 31/538 A61K 45/00<br />

A61P 1/04 A61P 3/10<br />

A61P 9/10 A61P 13/02<br />

A61P 13/10 A61P 17/00<br />

A61P 17/02 A61P 17/04<br />

A61P 19/02 A61P 25/00<br />

A61P 25/04 A61P 25/06<br />

A61P 27/16 A61P 29/00<br />

A61P 35/00 A61P 37/08<br />

C07D 413/14<br />

(25) Ja (26) En<br />

(21) 0684<strong>36</strong>88.0 (22) 22.12.2006<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(43) 10.09.2008<br />

(86) JP 2006/326314 22.12.2006<br />

(87) WO 2007/074916 2007/27 05.07.2007<br />

(30) 28.12.2005 JP 2005377754<br />

05.01.2006 US 756296 P<br />

(54) 3,4-DIHYDROBENZOXAZIN-VERBINDUNG<br />

UND HEMMER DER VANILLOID-REZEP-<br />

TOR-TYP1(VR1)-AKTIVITÄT<br />

3,4-DIHYDROBENZOXAZINE COMPOUND<br />

AND INHIBITOR OF VANILLOID<br />

RECEPTOR TYPE 1 (VR1) ACTIVITY<br />

COMPOSE DE 3,4-DIHYDROBENZOXA-<br />

ZINE ET INHIBITEUR DE L'ACTIVITE DU<br />

RECEPTEUR DE VANILLOIDE DE TYPE 1<br />

(VR1)<br />

(73) Japan Tobacco Inc., 2-1, Toranomon 2chome,<br />

Minato-ku, Tokyo 105-8422, JP<br />

(72) KOGA, Yoshihisa, Osaka 569-1125, JP<br />

YATA, Shinji, Osaka 569-1125, JP<br />

YAMASAKI, Takayuki, Osaka 569-1125, JP<br />

MATSUMOTO,Tatsuya, Osaka 569-1125, JP

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!